Cargando…
The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy
HGF/MET pathway mediates cancer initiation and development. Thus, inhibition on HGF-initiated MET signaling pathway would provide a new approach to cancer targeted therapeutics. In our study, we identified a targeting peptide candidate binding to HGF which was named HGF binding peptide-1 (HGP-1) via...
Autores principales: | Chen, Lisha, Li, Chunlin, Zhu, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745783/ https://www.ncbi.nlm.nih.gov/pubmed/26254225 |
Ejemplares similares
-
Harnessing the HGP for Public Health
por: Freeman, K
Publicado: (2004) -
The international Human Genome Project (HGP) and China’s contribution
por: Wang, Xiaoling, et al.
Publicado: (2017) -
Factores relacionados a la mortalidad perinatal en el HGP no. 71
por: Cruz Barrera, María Esther
Publicado: (2004) -
The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy
por: Ehrhardt, Michael, et al.
Publicado: (2014) -
Construction of HGF-Displaying Yeast by Cell Surface Engineering
por: Shibasaki, Seiji, et al.
Publicado: (2022)